Education
About Us
Working with TipRanks
Follow Us
Alzinova AB (SE:ALZ)
:ALZ
ALZ Stock Chart & Stats
kr1.64
-kr0.14(-4.96%)
At close: 4:00 PM EST
kr1.64
-kr0.14(-4.96%)
Day’s Range― - ―
52-Week Rangekr1.08 - kr3.82
Previous CloseN/A
Volume98.89K
Average Volume (3M)655.64K
Market Cap
kr164.00M
Enterprise Valuekr117.37M
Total Cash (Recent Filing)kr485.00K
Total Debt (Recent Filing)kr800.00K
Price to Earnings (P/E)―
Beta-0.05
Next Earnings
Feb 26, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.07
Shares Outstanding104,323,586
10 Day Avg. Volume664,473
30 Day Avg. Volume655,642
Financial Highlights & Ratios
PEG Ratio0.46
Price to Book (P/B)1.87
Price to Sales (P/S)7703.54
P/FCF Ratio-6.24
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ALZ FAQ
What was Alzinova AB’s price range in the past 12 months?
Alzinova AB lowest stock price was kr1.08 and its highest was kr3.82 in the past 12 months.
What is Alzinova AB’s market cap?
Alzinova AB’s market cap is kr164.00M.
When is Alzinova AB’s upcoming earnings report date?
Alzinova AB’s upcoming earnings report date is Feb 26, 2026 which is in 70 days.
How were Alzinova AB’s earnings last quarter?
Alzinova AB released its earnings results on Nov 13, 2025. The company reported -kr0.067 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.067.
Is Alzinova AB overvalued?
According to Wall Street analysts Alzinova AB’s price is currently Overvalued.
Does Alzinova AB pay dividends?
Alzinova AB does not currently pay dividends.
What is Alzinova AB’s EPS estimate?
Alzinova AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alzinova AB have?
Alzinova AB has 104,323,586 shares outstanding.
What happened to Alzinova AB’s price movement after its last earnings report?
Alzinova AB reported an EPS of -kr0.067 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 28.525%.
Which hedge fund is a major shareholder of Alzinova AB?
Currently, no hedge funds are holding shares in SE:ALZ
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Alzinova AB
Alzinova AB (ALZ) is a biotechnology company focused on developing innovative immunotherapy-based solutions for the treatment of Alzheimer's disease. The company operates within the healthcare sector, primarily concentrating on the discovery and development of novel therapeutic candidates aimed at targeting harmful amyloid-beta aggregates that are implicated in Alzheimer's pathology. Alzinova's core product is its proprietary drug candidates, including ALZ-101, which is in clinical development stages.
Technical Analysis
Biosergen AB
―
Nanologica AB
―
Biovica International AB Class B
―
Modus Therapeutics Holding AB
―
NextCell Pharma AB
―